Paul Chaplin
Chief Executive Officer presso BAVARIAN NORDIC A/S
Profilo
Paul Chaplin is currently the President & Chief Executive Officer at Bavarian.
Nordic A.
He is also the President at Bavarian Nordic, Inc. Additionally, he serves as the General Manager at Bavarian Nordic GmbH.
Dr. Chaplin holds a doctorate degree from the University of Bristol.
Posizioni attive di Paul Chaplin
Società | Posizione | Inizio |
---|---|---|
BAVARIAN NORDIC A/S | Chief Executive Officer | 28/05/2014 |
Bavarian Nordic GmbH
Bavarian Nordic GmbH BiotechnologyHealth Technology Part of Bavarian Nordic A/S, Bavarian Nordic GmbH engages in research and development in biotechnology for cancer and infectious diseases. The private company is based in Martinsried, Germany. The German company was founded in 2014. Paul Chaplin has been the CEO of the company since 1999. | Corporate Officer/Principal | 03/03/2011 |
Bavarian Nordic, Inc.
Bavarian Nordic, Inc. Miscellaneous Commercial ServicesCommercial Services Bavarian Nordic, Inc. engages in researching and manufacturing drugs to treat cancer. The company is headquartered in Morrisville, NC. | President | - |
Formazione di Paul Chaplin
University of Bristol | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
BAVARIAN NORDIC A/S | Health Technology |
Aziende private | 2 |
---|---|
Bavarian Nordic, Inc.
Bavarian Nordic, Inc. Miscellaneous Commercial ServicesCommercial Services Bavarian Nordic, Inc. engages in researching and manufacturing drugs to treat cancer. The company is headquartered in Morrisville, NC. | Commercial Services |
Bavarian Nordic GmbH
Bavarian Nordic GmbH BiotechnologyHealth Technology Part of Bavarian Nordic A/S, Bavarian Nordic GmbH engages in research and development in biotechnology for cancer and infectious diseases. The private company is based in Martinsried, Germany. The German company was founded in 2014. Paul Chaplin has been the CEO of the company since 1999. | Health Technology |
- Borsa valori
- Insiders
- Paul Chaplin